These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Factors conditioning the occurrence and entity of intraventricular obstruction in hypertrophic cardiomyopathy]. Astorri E G Ital Cardiol; 1981; 11(8):1141-50. PubMed ID: 7035262 [No Abstract] [Full Text] [Related]
3. [Cardiac pacemaker for the treatment of obstructive hypertrophic cardiomyopathy, a concept which is gaining ground]. Kappenberger L; Jeanrenaud X; Aebischer N Schweiz Med Wochenschr; 1995 Oct; 125(41):1950-5. PubMed ID: 7481653 [TBL] [Abstract][Full Text] [Related]
4. Tri-leaflet mitral valve in combination with hypertrophic cardiomyopathy. Irwin RB; Macnab A; Schmitt M Eur Heart J; 2011 Mar; 32(5):534. PubMed ID: 20937599 [No Abstract] [Full Text] [Related]
5. Dealing with a special group: hypertrophic cardiomyopathy. The role of electrophysiology and pacing in hypertrophic cardiomyopathy. de Sousa J Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V51-3. PubMed ID: 10582459 [No Abstract] [Full Text] [Related]
6. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future. Ommen SR; Shah PM; Tajik AJ Heart; 2008 Oct; 94(10):1276-81. PubMed ID: 18653577 [No Abstract] [Full Text] [Related]
7. [Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy. A comparison of objective hemodynamic and exercise end points]. Primo J; Tajik AJ Rev Port Cardiol; 1999 Nov; 18(11):1079-81. PubMed ID: 10608168 [No Abstract] [Full Text] [Related]
14. Appraisal of dual-chamber pacing therapy in hypertrophic cardiomyopathy: too soon for a rush to judgment? Maron BJ J Am Coll Cardiol; 1996 Feb; 27(2):431-2. PubMed ID: 8557916 [No Abstract] [Full Text] [Related]